8 unknown. 8 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Unknown 8 |
| Phase 1 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Rapamycin: new trials by email Literature Review of Rapamycin trials Research Report on Rapamycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage Rapamycin - Communicating Hydrocephalus, Cerebral Intraventricular Hemorrhage | Phase 2 | Unknown | Beijing Tiantan Hospital | 53 | 2024-08-01 | 2024-08-21 |
| Sirolimus for Graves' Orbitopathy (GO) Sirolimus - Graves Ophthalmopathy | Phase 2 | Unknown | University of Pisa | 54 | 2023-06-01 | 2023-03-15 |
| Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma Sirolimus - Hemangioendothelioma | Phase 2 | Unknown | West China Hospital | 30 | 2022-04-05 | 2024-01-24 |
| Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis Sirolimus - Lupus Nephritis, Immunosuppression | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 20 | 2021-06-30 | 2021-05-19 |
| The Efficacy and Safety of Sirolimus for Plastic Bronchitis Sirolimus - Plastic Bronchitis | Phase 2 | Unknown | Peking Union Medical College Hospital | 10 | 2019-05-06 | 2019-05-10 |
| Study of Sirolimus in Patients With Advanced Pancreatic Cancer Sirolimus - Pancreatic Cancer | Phase 1 / Phase 2 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 36 | 2018-06-01 | 2018-09-07 |
| Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection CD4+CD25+CD127lowFoxP3+ T regulatory cells injection, Alemtuzumab, Mycophenolate mofetil - End-Stage Renal Disease, Kidney Failure | Phase 1 / Phase 2 | Unknown | Pirogov Russian National Research Medical University | 30 | 2011-10-01 | 2011-11-18 |
| Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM sirolimus - Tuberous Sclerosis, Lymphangioleiomyomatosis | Phase 2 | Unknown | Cardiff University | 14 | 2005-10-01 | 2008-04-30 |
Cerebral Intraventricular Hemorrhage (1) · Graves Ophthalmopathy (1) · Hemangioendothelioma (1) · Hydrocephalus (1) · Kaposiform Hemangioendothelioma (1) · Kidney Failure, Chronic (1) · Lupus Nephritis (1) · Lymphangioleiomyomatosis (1) · Pancreatic Neoplasms (1) · Renal Insufficiency (1) · Tuberous Sclerosis (1)
Peking Union Medical College Hospital (2) · Beijing Tiantan Hospital (1) · Cardiff University (1) · Pirogov Russian National Research Medical University (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · University of Pisa (1) · West China Hospital (1)
China (4) · Italy (1) · Russia (1) · United Kingdom (1)
Guoyi Gao, MD (1) · Julian R Sampson, DM (1) · Kai-Feng Xu, MD (1) · Michael M. Kaabak, M.D. Ph.D. (1) · Runfa Tian, MD (1) · Svetlana N. Bykovskaia, M.D. Ph.D. (1) · Tingbo Liang, MD Ph.D (1) · Xue-mei Li, MD (1) · Yi Ji, MD, PhD (1)
PMID 21525172, PMID 22871490, PMID 28486787, PMID 31489702, PMID 32014025, PMID 33580918, PMID 35030255, PMID 36803604